| P/E (FY) | 14.2 | Sales (TTM) | $5.52B |
| Earnings (TTM) | $133.5M | ROE | 8.63% |
| Net Margin | 2.68% | ROIC | 13.50% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | −1.93% | Sales Growth 3Y | 5.76% |
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment treats conditions such as respiratory and pulmonary disease, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment provides therapy for brain and spinal cord injuries, strokes, and orthopedic conditions, while the Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation.
| Market Cap | $2.05B | Trading Days | 4212 |
| 52W High | 16.99 |
| 52W Low | 11.65 |
| % Off High | −2.83% |
| YTD | 12.08% | 1Y | 10.72% |
| 3Y | 1.20% | 5Y | −20.89% |
| 10Y | 208.56% | Since incept. (ann.) | 8.85% |
| Ann. Volatility (1Y) | 31.18% | Ann. Volatility (3Y) | 35.47% |
| Sharpe (1Y) | 0.49 | Sharpe (3Y) | 0.18 |
| Max Drawdown (1Y) | −22.82% | Max Drawdown (3Y) | −45.06% |
| Beta (3Y, vs SPY) | 0.70 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| MD | Pediatrix Medical Group, Inc. | $2.20B | 13.8 |
| EHC | Encompass Health Corp | $11.29B | 20.5 |
| NEOG | NEOGEN CORP | $2.05B | — |
| VRDN | Viridian Therapeutics, Inc.\DE | $2.05B | — |
| PVLA | PALVELLA THERAPEUTICS, INC. | $2.05B | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | $2.04B | — |
| IMUX | IMMUNIC, INC. | $2.03B | — |
| SION | Sionna Therapeutics, Inc. | $2.02B | — |
| BHVN | Biohaven Ltd. | $2.02B | — |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.08B | 13.2 |
| ADMA | ADMA BIOLOGICS, INC. | $2.02B | 14.5 |
| ATRC |
| AtriCure, Inc. |
| $2.08B |
| — |